Work

Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.1020

Authors: Steven J. Isakoff, Lei He, Erica L. Mayer, Paul E. Goss, Tiffany A. Traina, Lisa A. Carey, Karen Krag, Minetta C. Liu, Hope S. Rugo, Vered Stearns, Steven E. Come, Paula D. Ryan, Dianne M. Finkelstein, Anne-Renee Hartman, Judy Ellen Garber, Kirsten Timms, Eric P. Winer, Leif W. Ellisen

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, University of North Carolina at Chapel Hill, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Beth Israel Deaconess Medical Center, Myriad Genetics, Harvard University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891245069

Cites:

Cited by: 12

Related to: 10